The last 5 years have seen major shifts in defining whom to test and how to treat
Helicobacter pylori infection. Peptic ulcer has changed from a chronic disease to a one-off …

The purpose of this CPU Expert Review is to provide clinicians with guidance on the
management of Helicobacter pylori after an initial attempt at eradication therapy fails …

Background & aims Novel, effective treatments for Helicobacter pylori infection are needed.
This study evaluated the efficacy of vonoprazan, a potassium-competitive acid blocker, vs …

Helicobacter pylori (H. pylori) infection, which affects approximately half of the world's
population, remains a serious public health problem. As H. pylori infection leads to a number …

Despite the recent decrease in overall prevalence of Helicobacter pylori infection, morbidity
and mortality rates associated with gastric cancer remain high. The antimicrobial resistance …

Helicobacter pylori (H. pylori) is a 0.5–1 µm wide, 2–4 µm long, short helical, S-shaped
Gram-negative microorganism. It is mostly found in the pyloric region of the stomach and …

Rapid diagnosis and treatment application in the early stages of H. pylori infection plays an
important part in inhibiting the transmission of this infection as this bacterium is involved in …

The high prevalence of Helicobacter pylori and the variety of gastroduodenal diseases
caused by this pathogen necessitate the use of only accurate methods both for the primary …

Helicobacter pylori infection remains one of the most prevalent infections worldwide,
especially in low-resource countries, and the major risk factor for peptic ulcer and gastric …

Background & Aims The decline in Helicobacter pylori cure rates emphasizes the need for
readily available methods to determine antimicrobial susceptibility. Our aim was to compare …